AbCellera Biologics Inc.
ABCLNASDAQHealthcare● Active
$5.42
$-0.20(-3.56%)
Market Cap$1.7B
P/E Ratio—
52W High$6.79
52W Low$2.525
AbCellera Biologics Inc. (ABCL) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ABCL · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $533.83M | $625.61M | $760.59M | $886.49M | $722.98M |
| Net Receivables | $153.40M | $92.13M | $64.38M | $38.59M | $160.58M |
| Inventory | $6.34M | $0.00M | $1.11M | $1.53M | $1.67M |
| Total Current Assets | $728.23M | $751.37M | $871.99M | $1025.49M | $929.80M |
| PP&E Net | $428.00M | $340.43M | $287.70M | $217.25M | $111.62M |
| Goodwill | $47.81M | $47.81M | $47.81M | $47.81M | $47.81M |
| Intangible Assets | $38.38M | $42.11M | $120.42M | $131.50M | $148.39M |
| Total Assets | $1356.95M | $1360.55M | $1488.09M | $1540.91M | $1318.57M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $25.23M | $34.35M | $25.51M | $14.83M | $14.92M |
| Total Current Liabilities | $64.31M | $76.61M | $119.01M | $118.32M | $120.68M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $390.05M | $304.47M | $335.78M | $307.63M | $292.84M |
| Stockholders Equity | |||||
| Retained Earnings | ($29.48M) | $116.93M | $279.79M | $426.19M | $267.67M |
| Total Stockholders Equity | $966.90M | $1056.08M | $1152.32M | $1233.28M | $1025.73M |
| Total Liab & Equity(computed) | $1356.95M | $1360.55M | $1488.09M | $1540.91M | $1318.57M |
| Debt Summary | |||||
| Total Debt | $143.22M | $65.36M | $77.38M | $82.26M | $40.06M |
| Net Debt | $14.71M | ($90.96M) | ($55.94M) | ($304.28M) | ($436.08M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more AbCellera Biologics Inc. data
About AbCellera Biologics Inc. (ABCL) Balance Sheet
AbCellera Biologics Inc. (ABCL) balance sheet shows total assets of $1.36B with cash of $0.53B. Total liabilities are $0.39B, total debt $0.14B, and stockholders equity $0.97B.
Frequently asked questions
ABCL · 4 questionsAbCellera Biologics Inc. has total debt of $0.14B with net debt of $0.01B.
ABCL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10